Ticagrelor inhibits the NLRP3 inflammasome to protect against inflammatory disease independent of the P2Y12 signaling pathway-Reference-Cited by-同舟云学术

Ticagrelor inhibits the NLRP3 inflammasome to protect against inflammatory disease independent of the P2Y12 signaling pathway

Published:2020-06-10 Issue:5 Volume:18 Page:1278-1289
ISSN:1672-7681
Container-title:Cellular & Molecular Immunology
language:en
Short-container-title:Cell Mol Immunol

Author:

Huang Bo,Qian Yufeng,Xie Shujun,Ye Xianhua,Chen Hanwen^ORCID,Chen Zhifeng,Zhang Lihuan,Xu Jinming,Hu Hu,Ma Shenglin,Héroux Paul,Wang Di,Shen Han-Ming,Wu Yihua,Xia Dajing

Funder

National Natural Science Foundation of China

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Link

http://www.nature.com/articles/s41423-020-0444-5.pdf

Reference53 articles.

1. Rollini, F., Franchi, F. & Angiolillo, D. J. Switching P2Y12-receptor inhibitors in patients with coronary artery disease. Nat. Rev. Cardiol. 13, 11–27 (2016).

2. Gaglia, M. A. Jr. & Waksman, R. Overview of the 2010 Food and Drug Administration Cardiovascular and Renal Drugs Advisory Committee meeting regarding ticagrelor. Circulation 123, 451–456 (2011).

3. Wallentin, L. et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N. Engl. J. Med. 361, 1045–1057 (2009).

4. Alexopoulos, D. et al. Ticagrelor versus prasugrel in acute coronary syndrome patients with high on-clopidogrel platelet reactivity following percutaneous coronary intervention: a pharmacodynamic study. J. Am. Coll. Cardiol. 60, 193–199 (2012).

5. Roffi, M. et al. 2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur. Heart J. 37, 267–315 (2016).

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Igniting hope: Harnessing NLRP3 inflammasome-GSDMD-mediated pyroptosis for cancer immunotherapy;Life Sciences;2024-10

2. Platelets, inflammation, and purinergic receptors in chronic kidney disease;Kidney International;2024-09

3. Tirofiban mediates neuroprotective effects in acute ischemic stroke by reducing inflammatory response;Neuroscience;2024-09

4. Crosslinked PVA-g-poly(AMPS) Nanogels for Enhanced Solubility and Dissolution of Ticagrelor: Synthesis, Characterization, and Toxicity Evaluation;ACS Omega;2024-05-02

5. GSNOR negatively regulates the NLRP3 inflammasome via S-nitrosation of MAPK14;Cellular & Molecular Immunology;2024-04-03